IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 178 filers reported holding IMPAX LABORATORIES INC in Q4 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $303,000 | -22.9% | 15,583 | -34.0% | 0.00% | -33.3% |
| Q4 2017 | $393,000 | +58.5% | 23,599 | +173.9% | 0.00% | +50.0% |
| Q2 2016 | $248,000 | -5.3% | 8,615 | +5.2% | 0.00% | 0.0% |
| Q1 2016 | $262,000 | -4.4% | 8,191 | +27.9% | 0.00% | 0.0% |
| Q4 2015 | $274,000 | -6.8% | 6,404 | -23.3% | 0.00% | 0.0% |
| Q3 2015 | $294,000 | +143.0% | 8,351 | +216.9% | 0.00% | +100.0% |
| Q2 2015 | $121,000 | +26.0% | 2,635 | +28.5% | 0.00% | 0.0% |
| Q1 2015 | $96,000 | +47.7% | 2,051 | -0.6% | 0.00% | 0.0% |
| Q4 2014 | $65,000 | +16.1% | 2,063 | -13.0% | 0.00% | – |
| Q3 2014 | $56,000 | -24.3% | 2,370 | -3.3% | 0.00% | -100.0% |
| Q2 2014 | $74,000 | +13.8% | 2,452 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $65,000 | +6.6% | 2,452 | +0.5% | 0.00% | 0.0% |
| Q4 2013 | $61,000 | -64.5% | 2,440 | -70.9% | 0.00% | -50.0% |
| Q3 2013 | $172,000 | +95.5% | 8,389 | +89.5% | 0.00% | +100.0% |
| Q2 2013 | $88,000 | – | 4,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,032,187 | $24,463,000 | 8.84% |
| Asymmetry Capital Management, L.P. | 164,156 | $3,890,000 | 6.76% |
| Hound Partners | 6,204,588 | $147,049,000 | 3.96% |
| Sivik Global Healthcare LLC | 130,000 | $3,081,000 | 1.55% |
| Tradewinds Global Investors, LLC | 49,661 | $1,177,000 | 1.45% |
| SECTOR GAMMA AS | 409,964 | $7,318,000 | 1.28% |
| Orbimed Advisors | 3,787,500 | $89,764,000 | 1.02% |
| Iguana Healthcare Management, LLC | 200,000 | $4,740,000 | 0.84% |
| Seven Bridges Advisors LLC | 37,409 | $887,000 | 0.79% |
| Penn Capital Management Company, LLC | 454,597 | $10,808,000 | 0.73% |